Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Operating Expenses (2018 - 2025)

Health Catalyst's Operating Expenses history spans 8 years, with the latest figure at $125.5 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 140.39% year-over-year to $125.5 million; the TTM value through Dec 2025 reached $312.5 million, up 48.41%, while the annual FY2025 figure was $312.5 million, 48.41% up from the prior year.
  • Operating Expenses reached $125.5 million in Q4 2025 per HCAT's latest filing, up from $55.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $125.5 million in Q4 2025 to a low of $47.7 million in Q3 2024.
  • Average Operating Expenses over 5 years is $65.8 million, with a median of $62.6 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: decreased 27.23% in 2023, then surged 140.39% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $75.6 million in 2021, then fell by 10.32% to $67.8 million in 2022, then fell by 6.65% to $63.3 million in 2023, then fell by 17.54% to $52.2 million in 2024, then soared by 140.39% to $125.5 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Operating Expenses are $125.5 million (Q4 2025), $55.3 million (Q3 2025), and $75.3 million (Q2 2025).